» Articles » PMID: 35944927

Molecular Heterogeneity and Commonalities in Pancreatic Cancer Precursors with Gastric and Intestinal Phenotype

Abstract

Objective: Due to the limited number of modifiable risk factors, secondary prevention strategies based on early diagnosis represent the preferred route to improve the prognosis of pancreatic ductal adenocarcinoma (PDAC). Here, we provide a comparative morphogenetic analysis of PDAC precursors aiming at dissecting the process of carcinogenesis and tackling the heterogeneity of preinvasive lesions.

Design: Targeted and whole-genome low-coverage sequencing, genome-wide methylation and transcriptome analyses were applied on a final collective of 122 morphologically well-characterised low-grade and high-grade PDAC precursors, including intestinal and gastric intraductal papillary mucinous neoplasms (IPMN) and pancreatic intraepithelial neoplasias (PanIN).

Results: Epigenetic regulation of mucin genes determines the phenotype of PDAC precursors. PanIN and gastric IPMN display a ductal molecular profile and numerous similarly regulated pathways, including the Notch pathway, but can be distinguished by recurrent deletions and differential methylation and, in part, by the expression of mucin-like 3. Intestinal IPMN are clearly distinct lesions at the molecular level with a more instable genotype and are possibly related to a different ductal cell compartment.

Conclusions: PDAC precursors with gastric and intestinal phenotype are heterogeneous in terms of morphology, genetic and epigenetic profile. This heterogeneity is related to a different cell identity and, possibly, to a different aetiology.

Citing Articles

Subtype-associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms.

Nemeth K, Mezei E, Voros J, Borka K, Pesti A, Kenessey I J Pathol Clin Res. 2025; 11(2):e70019.

PMID: 39969214 PMC: 11837281. DOI: 10.1002/2056-4538.70019.


The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers.

Mottini C, Auciello F, Manni I, Pilarsky C, Caputo D, Caracciolo G J Exp Clin Cancer Res. 2024; 43(1):198.

PMID: 39020414 PMC: 11256648. DOI: 10.1186/s13046-024-03117-5.


[Histopathologic diagnosis of solid and cystic pancreatic lesions with a focus on ductal adenocarcinoma : A vademecum for daily practice].

Esposito I, Yavas A, Haberle L Pathologie (Heidelb). 2024; 45(1):5-18.

PMID: 38191761 DOI: 10.1007/s00292-023-01288-0.


Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.

Jiang Z, Zheng X, Li M, Liu M Front Med. 2023; 17(6):1135-1169.

PMID: 38151666 DOI: 10.1007/s11684-023-1050-6.


Cancer-on-chip: a 3D model for the study of the tumor microenvironment.

Cauli E, Polidoro M, Marzorati S, Bernardi C, Rasponi M, Lleo A J Biol Eng. 2023; 17(1):53.

PMID: 37592292 PMC: 10436436. DOI: 10.1186/s13036-023-00372-6.


References
1.
Roth S, Zamzow K, Gaida M, Heikenwalder M, Tjaden C, Hinz U . Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. EBioMedicine. 2020; 54:102714. PMC: 7132171. DOI: 10.1016/j.ebiom.2020.102714. View

2.
Mateos R, Nakagawa H, Hirono S, Takano S, Fukasawa M, Yanagisawa A . Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas. Cancer Med. 2019; 8(10):4565-4573. PMC: 6712468. DOI: 10.1002/cam4.2340. View

3.
Balachandran V, Luksza M, Zhao J, Makarov V, Moral J, Remark R . Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017; 551(7681):512-516. PMC: 6145146. DOI: 10.1038/nature24462. View

4.
Pea A, Yu J, Rezaee N, Luchini C, He J, Dal Molin M . Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Ann Surg. 2016; 266(1):133-141. PMC: 5243861. DOI: 10.1097/SLA.0000000000001817. View

5.
Kleeff J, Korc M, Apte M, La Vecchia C, Johnson C, Biankin A . Pancreatic cancer. Nat Rev Dis Primers. 2016; 2:16022. DOI: 10.1038/nrdp.2016.22. View